You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Carcinoma, Renal Cell

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Renal Cell Carcinoma Trial in Houston (Tivozanib, Nivolumab)

Not yet recruiting
  • Renal Cell Carcinoma
  • Houston, Texas
    M D Anderson Cancer Center
Sep 19, 2023

Advanced Renal Cell Carcinoma Trial (Botensilimab, Balstilimab, Ipilimumab)

Not yet recruiting
  • Advanced Renal Cell Carcinoma
  • (no location specified)
Jun 23, 2023

Advanced Clear Cell Renal Carcinoma (Ccrcc), Papillary Renal Cell Carcinoma (Prcc) Trial run by the National Cancer Institute

Not yet recruiting
  • Advanced Clear Cell Renal Carcinoma (Ccrcc)
  • Papillary Renal Cell Carcinoma (Prcc)
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 2, 2023

Renal Cancer, Kidney Cancer, Renal Cell Carcinoma Trial in Aurora (Axitinib, Pembrolizumab)

Not yet recruiting
  • Renal Cancer
  • +3 more
  • Aurora, Colorado
    University of Colorado Cancer Center
Jul 24, 2023

Renal Cell Carcinoma Trial in Haifa (PROSENSE™)

Active, not recruiting
  • Renal Cell Carcinoma
  • PROSENSE™
  • Haifa, Israel
  • +1 more
Dec 21, 2022

Renal Cell Carcinoma Trial in Tabriz (Sodium Pentaborate)

Not yet recruiting
  • Renal Cell Carcinoma
  • Sodium Pentaborate
  • Tabriz, East Azarbayejan, Iran, Islamic Republic of
    Imam Reza hospital and Clinic of Salamat
Mar 23, 2023

Clear Cell Renal Cell Carcinoma Trial in Beijing (68Ga-NY104)

Completed
  • Clear Cell Renal Cell Carcinoma
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Feb 6, 2023

Renal Cell Carcinoma Trial in Philadelphia (Pembrolizumab infusion, Lenvatinib tablet)

Not yet recruiting
  • Renal Cell Carcinoma
  • Pembrolizumab infusion
  • Lenvatinib tablet
  • Philadelphia, Pennsylvania
    Abramson Cancer Center at University of Pennsylvania
Feb 8, 2023

First-line Treatment of Non-clear Renal Cell Carcinoma Trial (Fruquintinib combined with Serplulimab)

Not yet recruiting
  • First-line Treatment of Non-clear Renal Cell Carcinoma
  • Fruquintinib combined with Serplulimab
  • (no location specified)
Apr 16, 2023

Renal Cell Carcinoma Metastases to Pancreas

Completed
  • Surgery
    • (no location specified)
    May 21, 2023

    RCC, Renal Cell Carcinoma Trial in Dallas (Cabozantinib 80 MG, Cabozantinib 40Mg Tab, Nivolumab)

    Not yet recruiting
    • RCC
    • Renal Cell Carcinoma
    • Cabozantinib 80 MG
    • +2 more
    • Dallas, Texas
      UT Southwestern Medical Center
    Jul 3, 2023

    Renal Cancer, Renal Cell Carcinoma, Renal Cell Cancer Metastatic Trial

    Recruiting
    • Renal Cancer
    • +2 more
      • Amsterdam, Noord Holland, Netherlands
        Amsterdam UMC locatie VUMC
      Jan 20, 2023

      Renal Cell Carcinoma (RCC) Trial in Birmingham (Trans-arterial embolization (TAE))

      Not yet recruiting
      • Renal Cell Carcinoma (RCC)
      • Trans-arterial embolization (TAE)
      • Birmingham, Alabama
        University of Alabama at Birmingham
      Dec 5, 2022

      Fumarate Hydratase Deficient Renal Cell Carcinoma Trial (Tislelizumab, Lenvatinib)

      Not yet recruiting
      • Fumarate Hydratase Deficient Renal Cell Carcinoma
      • (no location specified)
      May 18, 2023

      Carcinoma, Renal Cell Trial in United States (Belzutifan)

      Recruiting
      • Carcinoma, Renal Cell
      • Boston, Massachusetts
      • +3 more
      Jan 27, 2023

      Urothelial Carcinoma, Renal Cell Carcinoma, Melanoma Trial (BGB-A445, Tislelizumab)

      Not yet recruiting
      • Urothelial Carcinoma
      • +2 more
      • (no location specified)
      Dec 15, 2022

      Learn About First and Later Lines of Medicines in Treating

      Completed
      • Metastatic Renal Cell Carcinoma
        • New York, New York
          Pfizer Headquarters
        May 12, 2023

        Renal Cell Carcinoma Trial (Neoadjuvant Lenvatinib, Neoadjuvant Pembrolizumab, Radical nephrectomy, IVC thrombectomy,

        Not yet recruiting
        • Renal Cell Carcinoma
        • Neoadjuvant Lenvatinib
        • +3 more
        • (no location specified)
        Dec 23, 2022

        Metastatic and/or Advanced Renal Cell Carcinoma, Treated With

        Completed
        Has Results
        • Carcinoma
        • Renal Cell
        • London, United Kingdom
          Pfizer UK
        Jan 9, 2023

        Develop Circulating Exosomes as Predictive Biomarkers for

        Recruiting
        • Renal Cell Carcinoma
        • Other: Blood and Urine Collection
        • Hangzhou, China
          An Zhao
        Jan 30, 2023

        Among Advanced Renal Cell Carcinoma Receiving Systemic

        Not yet recruiting
        • Carcinoma, Renal Cell
          • (no location specified)
          Sep 6, 2022

          Implementation of Shared Decision Making Strategy for Renal Cell

          Recruiting
          • Renal Cell Carcinoma
          • Renal Cell Carcinoma Metastatic
          • Decision aid
          • Nieuwegein, Utrecht, Netherlands
            St. Antonius Ziekenhuis
          Nov 28, 2022

          Renal Cell Carcinoma Trial in Beijing, Seoul (RO7247669, Tiragolumab, Pembrolizumab)

          Recruiting
          • Renal Cell Carcinoma
          • Beijing, China
          • +1 more
          Mar 28, 2023

          Renal Cancer Trial in Aarhus N

          Enrolling by invitation
          • Renal Cancer
            • Aarhus N, Denmark
              Urology Department Aarhus University Hospital
            Nov 21, 2023

            Metastatic Renal Cell Carcinoma Trial in Cleveland (Nivolumab, Ipilimumab)

            Active, not recruiting
            • Metastatic Renal Cell Carcinoma
            • Cleveland, Ohio
              Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Ca
            Jan 25, 2023